FOLFOX4 Combined With Endostar in Patients With Advanced Colorectal Cancer

NCT00813137 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasms

Interventions

DRUG: Folfox4 plus recombinant human endostatin (Endostar)

Sponsor

Simcere Pharmaceutical Co., Ltd

Collaborators

[object Object]